Northwest Biotherapeutics INC (NWBO) SEC Filings — 2024
15 SEC filings for Northwest Biotherapeutics INC (NWBO) in 2024.
Filings
- Northwest Biotherapeutics Secures New Loan Agreement — 8-K · Dec 26, 2024
- Northwest Biotherapeutics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Northwest Biotherapeutics Enters Material Definitive Agreement — 8-K · Nov 1, 2024
- Northwest Biotherapeutics Q2 2024: Assets $69.5M, Cash $550K — 10-Q · Aug 9, 2024
- Northwest Biotherapeutics Files 8-K — 8-K · Aug 2, 2024
- Northwest Biotherapeutics Files 8-K on Shareholder Votes — 8-K · Jul 3, 2024
- NW Bio Proxy Statement Filed for June 27th Annual Meeting — DEFA14A · Jun 25, 2024
- Northwest Biotherapeutics Files 8-K — 8-K · Jun 4, 2024
- Northwest Biotherapeutics Sets 2024 Annual Meeting for June 29 — DEF 14A · Jun 3, 2024
- Northwest Biotherapeutics Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 10, 2024
- Northwest Biotherapeutics Enters Material Definitive Agreement — 8-K · May 2, 2024
- Northwest Biotherapeutics Files 10-K/A Amendment — 10-K/A · Apr 29, 2024
- Northwest Biotherapeutics Announces Director and Executive Changes — 8-K · Mar 22, 2024
- Northwest Biotherapeutics Reports Officer and Director Changes — 8-K · Mar 14, 2024
- Northwest Biotherapeutics Inc. Files 2023 10-K Report — 10-K · Mar 5, 2024